Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia

Summary. The morphology, membrane markers and ultra‐structural cytochemistry of 39 cases of acute myeloid leukaemia (AML) with variable proportion (10–99%) of terminal deoxynucleotidyl transferase (TdT) positive blasts was compared with that of 134 cases of TdT negative AML. The incidence of TdT positive AML was 22.5% and this was significantly higher in poorly differentiated myeloblastic (M0 and M1) types (54%) than in all other FAB subtypes (10%; P<0.001). Our findings suggest heterogeneity among TdT positive cases. Whilst the majority correspond to genuine TdT positive AML in which evidence for exclusive myeloid nature was demonstrated by phenotypic, cytochemcal and ultrastructural markers, a distinct minority (22%) of cases had mixtures of lymphoid and myeloid blasts. A change in phenotype occurred in three out of six cases studied in relapse. There was no difference in the incidence of immuno‐globulin (Ig) gene rearrangement between TdT positive (two out of 12) and TdT negative (one out of 11) cases, although published data suggests that Ig gene rearrangement is significantly more common in TdT positive cases. The determination of TdT in AML allows the identification of cases of mixed acute leukaemia which probably represent proliferations of multipotent progenitor cells. The majority of TdT positive cases, nevertheless, correspond to immature types of myeloblastic leukaemia which may constitute a clinically distinct subgroup.

[1]  麻生 範雄.  Rearrangements of immunoglobulin and T cell receptor genes in cells from hematologic neoplasms , 1988 .

[2]  D. Catovsky,et al.  α, β and γ T‐cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias , 1987 .

[3]  D. Catovsky,et al.  Alpha, beta and gamma T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias. , 1987, British journal of haematology.

[4]  R. Winchester,et al.  High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase , 1987, The Journal of experimental medicine.

[5]  I Royston,et al.  Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. , 1987, The New England journal of medicine.

[6]  R. Foà,et al.  Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia , 1987, The Journal of experimental medicine.

[7]  J. Rowley,et al.  Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5. , 1987, Blood.

[8]  M. González,et al.  TdT activity in acute myeloid leukemias defined by monoclonal antibodies , 1986, American journal of hematology.

[9]  M. Minden,et al.  T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia , 1986, The Journal of experimental medicine.

[10]  M. Greaves,et al.  Lineage promiscuity in hemopoietic differentiation and leukemia. , 1986, Blood.

[11]  R. Marcus,et al.  Phenotypic conversion of TdT+ adult AML to CALLA+ ALL. , 2009, Scandinavian journal of haematology.

[12]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[13]  S. Stass,et al.  Unexpected heterogeneity in acute leukemia: mixed lineages and lineage switch. , 1985, Human pathology.

[14]  D. Catovsky,et al.  Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9 , 1985, Hematological oncology.

[15]  D. Catovsky,et al.  Biphenotypic leukaemia: a case of mixed T lymphoblastic and myeloblastic leukaemia. , 1985, Journal of clinical pathology.

[16]  D. Campana,et al.  A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. , 1985, Leukemia research.

[17]  C. Pui,et al.  Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. , 1985, Blood.

[18]  J. Dutcher,et al.  Terminal transferase positive acute promyelocytic leukemia: in vitro differentiation of a T-lymphocytic/promyelocytic hybrid phenotype. , 1985, Blood.

[19]  P. Neame,et al.  Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. , 1985, Blood.

[20]  David Baltimore,et al.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells , 1984, Nature.

[21]  C. Pui,et al.  ACUTE LEUKAEMIA WITH MIXED LYMPHOID AND MYELOID PHENOTYPE , 1984, British journal of haematology.

[22]  S. Stass,et al.  Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia. , 1984, Blood.

[23]  D. Catovsky,et al.  DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. , 1984, Molecular biology & medicine.

[24]  C. Pui,et al.  Acute leukaemia with mixed lymphoid and myeloid phenotype , 1984, British journal of haematology.

[25]  I. Bernstein,et al.  Stages of Myeloid Differentiation Identified by Monoclonal Antibodies , 1984 .

[26]  R. Gale,et al.  Hybrid acute leukemia. , 1984, Leukemia research.

[27]  V. Najfeld,et al.  TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings. , 1984, Blood.

[28]  C. H. Lee,et al.  Expression of terminal deoxynucleotidyl transferase in malignant myeloblasts. , 1983, American journal of clinical pathology.

[29]  P. Lansdorp,et al.  Monoclonal antibodies against human platelet glycoprotein IIIa , 1983, British journal of haematology.

[30]  Robert J. Mayer,et al.  Surface marker anaylsis of acute myeloblastic leukemia: identifi- cation of differentiation-associated phenotypes. , 1983 .

[31]  L. Smith,et al.  Lineage infidelity in acute leukemia. , 1983, Blood.

[32]  M. Greaves,et al.  Terminal deoxynucleotidyl transferase in acute myeloid leukaemia. , 1983, Leukemia research.

[33]  Weinstein,et al.  Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes. , 1983, Blood.

[34]  A. McMichael,et al.  Monoclonal Antibody to Human Platelet Glycoprotein I I. IMMUNOLOGICAL STUDIES , 1981, British journal of haematology.

[35]  D. Catovsky,et al.  Cytochemical markers of differentiation in acute leukemia. , 1981, Cancer research.

[36]  S. Stass,et al.  Terminal deoxynucleotidyl transferase‐positive acute myeloblastic leukemia , 1981, American journal of hematology.

[37]  G. Janossy,et al.  Terminal Deoxynucleotidyl Transferase Expression in Acute Non‐lymphoid Leukaemia: an Analysis by Immunofluorescence , 1981, British Journal of Haematology.

[38]  P. Edwards.  Monoclonal antibodies that bind to the human erythrocyte-membrane glycoproteins glycophorin A and Band 3 [proceedings]. , 1980, Biochemical Society transactions.

[39]  J. Shelhamer,et al.  Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Collier,et al.  The influence of haemoglobin on the inhibition of prostaglandin synthase by antiinflammatory drugs , 1980 .

[41]  F. Bollum.  Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. , 1979, Blood.

[42]  F. Bollum.  Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. , 1979, Blood.

[43]  D. Baltimore,et al.  Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. , 1975, The New England journal of medicine.